The vast clinical applicability of rituximab mandates a complete understanding of its adverse effect profile. We report a case of non-hodgkin's lymphoma on rituximab therapy progressing to heart failure. Patients undergoing chemotherapy have multiple comorbidities and thus astute drug selection and monitoring is imperative.